The University of Queensland (UQ) is one of Australia’s top research-intensive universities.
UQ’s investment in major infrastructure, in partnership with government, industry and donors, provides cutting-edge facilities and leading technologies for researchers to pursue their questions.
Together with multiple facilities specialising in characterisation, imaging, bioprocess development, gene sequencing, nanotechnology and many more across the University, the CAI forms a network of open-source facilities - the Central Research Platforms, which support researchers at all stages of their research journey - from discovery through to commercialisation and impact stages.
UQ Pro-Vice-Chancellor (Research Infrastructure), Professor Joe Shapter explains how UQ is advancing research through world-class capabilities in the latest Research Infrastructure News.
"As a research-intensive, Top 50 global university, UQ is renowned for the quality of its research as we search for answers to some of the world’s most challenging problems," Professor Joe Shapter said.
"Using the advanced equipment, high-performing facilities, and premier training and services available through our multi-million dollar research infrastructure, our researchers deliver some of the most transformative and groundbreaking research outcomes possible, thanks to the infrastructure provided to meet their requirements."
"Through numerous initiatives and partnerships with academia, government and industry, we have invested in central research platforms, national collaborative research infrastructure, funding initiatives and other allied services that deliver sustainable advantage to the University, our staff and our researchers."
CAI and the National Imaging Facility (NIF) Queensland node have been highlighted in UQ Research Infrastructure Case Studies which feature central research platforms delivering successful impact across research. These case studies include Counteracting Coronavirus, Reducing Stroke Impact and Targeting Brain Tumours.
CAI research capabilities highlighted in these studies are:
| Case Study | Capabilities |
| Counteracting Coronavirus | Processing of small molecules via NMR molecular structure determination tools, preclinical molecular imaging, vaccine component monitoring, vaccine safety testing, clinical tracing, long-term patient monitoring |
| Reducing Stroke Impact | Used PET technology to identify how Hi1a travels to various tissues in the body |
| Targeting Brain Tumours |
Imaging, metabolomics, NMR structural elucidation, free radical detection Imaging, probe development, radioactive PET tracers (NIF Queensland node) |
Advance your research and learn more about our Centre's capabilities in our facilities overview below:
To read more about UQ research services, equipment and facilities available for use, visit UQ Research Equipment and Infrastructure.
Media: Maria Moran, maria.moran@cai.uq.edu.au, +61 7 3365 1785
